Sidibeh, Cherno O.
Pereira, Maria J.
Abalo, Xesus M.
J. Boersma, Gretha
Skrtic, Stanko
Lundkvist, Per
Katsogiannos, Petros
Hausch, Felix
Castillejo-López, Casimiro
Eriksson, Jan W.
Funding for this research was provided by:
Diabetesfonden
Exodiab (Excellence Of Diabetes Research in Sweden)
Stiftelsen Familjen Ernfors Fond (SE)
Akademiska Sjukhuset
Svenska Sällskapet för Medicinsk Forskning
AstraZeneca R&D
Fundação para a Ciência e a Tecnologia (PT) (SFRH/BD/41044/2007 and PTDC/SAU-OSM/104124/2008)
M4 Award 2015 (BIO-1601-0003)
BMBF/ERA-IB grant ‘TACRODRUGS’ (031B0269B)
Vetenskapsrådet
Article History
Received: 16 March 2018
Accepted: 2 July 2018
First Online: 21 July 2018
Compliance with ethical standards
:
: S.S. is employed by AstraZeneca R&D. The other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.